Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13276
PUT
YieldMax AAPL Option Income Strategy ETF
APLY
$119M
| $16.2K | ﹤0.01% |
+900
| New | +$16.1K |
2024 Q4
0 quarters
|
|
13277
Brown & Brown
BRO
$20.4B
| $16.2K | ﹤0.01% |
+159
| New | +$17K |
2024 Q4
0 quarters
|
|
13278
PUT
Dimensional US Core Equity Market ETF
DFAU
$13B
| $16.2K | ﹤0.01% |
+400
| New | +$16.3K |
2024 Q4
0 quarters
|
|
13279
PUT
Abeona Therapeutics
ABEO
$292M
| $16.2K | ﹤0.01% |
2,900
-15,100
| -84% | -$92.9K |
2023 Q4
4 quarters
|
|
13280
PUT
Epsilon Energy
EPSN
$184M
| $16.1K | ﹤0.01% |
2,600
+2,400
| +1,200% | +$14.1K |
2024 Q3
1 quarter
|
|
13281
PUT
Zedge
ZDGE
$46M
| $16.1K | ﹤0.01% |
6,000
+1,900
| +46% | +$5.53K |
2020 Q4
16 quarters
|
|
13282
PUT
Newegg Commerce
NEGG
$250M
| $16.1K | ﹤0.01% |
2,035
+400
| +24% | +$4.82K |
2021 Q3
13 quarters
|
|
13283
PUT
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$293M
| $16.1K | ﹤0.01% |
+900
| New | +$17.8K |
2024 Q4
0 quarters
|
|
13284
PUT
Siebert Financial
SIEB
$92.1M
| $16.1K | ﹤0.01% |
+5,100
| New | +$13.8K |
2024 Q4
0 quarters
|
|
13285
CALL
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$523M
| $16.1K | ﹤0.01% |
+200
| New | +$16.1K |
2024 Q4
0 quarters
|
|
13286
ProShares UltraShort Financials
SKF
$12.7M
| $16.1K | ﹤0.01% |
457
-999
| -69% | -$35.9K |
2024 Q3
1 quarter
|
|
|
TIXT
13287
CALL
DELISTED
TELUS International
TIXT
| $16.1K | ﹤0.01% |
4,100
-1,800
| -31% | -$6.82K |
2023 Q2
6 quarters
|
|
13288
CALL
CuriosityStream
CURI
$173M
| $16.1K | ﹤0.01% |
10,500
+800
| +8% | +$1.54K |
2024 Q3
1 quarter
|
|
13289
PUT
Acacia Research
ACTG
$420M
| $16.1K | ﹤0.01% |
3,700
-9,100
| -71% | -$41.2K |
2022 Q4
8 quarters
|
|
13290
PUT
SunCoke Energy
SXC
$844M
| $16.1K | ﹤0.01% |
1,500
-17,800
| -92% | -$191K |
2022 Q4
8 quarters
|
|
13291
PUT
Design Therapeutics
DSGN
$777M
| $16K | ﹤0.01% |
2,600
-100
| -4% | -$579 |
2022 Q4
8 quarters
|
|
13292
PUT
ProShares UltraShort Russell2000
TWM
$64M
| $16K | ﹤0.01% |
360
-60
| -14% | -$2.57K |
2024 Q3
1 quarter
|
|
|
BLRX
13293
CALL
BioLineRX
BLRX
$11.5M
| $16K | ﹤0.01% |
1,878
+715
| +61% | +$10.5K |
2023 Q2
6 quarters
|
|
13294
CALL
Southern First Bancshares
SFST
$575M
| $15.9K | ﹤0.01% |
+400
| New | +$16K |
2024 Q4
0 quarters
|
|
|
CMBT
13295
CALL
CMB.TECH NV
CMBT
$5.8B
| $15.9K | ﹤0.01% |
1,600
-1,100
| -41% | -$14.3K |
2024 Q3
1 quarter
|
|
|
BRFS
13296
PUT
DELISTED
BRF SA
BRFS
| $15.9K | ﹤0.01% |
+3,900
| New | +$16.9K |
2024 Q4
0 quarters
|
|
13297
PUT
Accuray
ARAY
$36M
| $15.8K | ﹤0.01% |
8,000
-4,800
| -38% | -$9.08K |
2024 Q3
1 quarter
|
|
13298
PUT
Atea Pharmaceuticals
AVIR
$411M
| $15.7K | ﹤0.01% |
4,700
-24,300
| -84% | -$80.8K |
2022 Q4
8 quarters
|
|
|
GAU
13299
CALL
Galiano Gold
GAU
$521M
| $15.7K | ﹤0.01% |
12,800
+9,300
| +266% | +$13.4K |
2023 Q1
7 quarters
|
|
13300
PUT
InnovAge Holding
INNV
$1.23B
| $15.7K | ﹤0.01% |
+4,000
| New | +$20.7K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.